234 related articles for article (PubMed ID: 12595806)
1. [Glioblastomas: clinical study and search for prognostic factors].
Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
[TBL] [Abstract][Full Text] [Related]
2. Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.
Lutterbach J; Bartelt S; Momm F; Becker G; Frommhold H; Ostertag C
Cancer; 2005 Mar; 103(6):1234-44. PubMed ID: 15666327
[TBL] [Abstract][Full Text] [Related]
3. [The effect of extent of tumor resection on the outcome of combined therapy in patients with glioblastoma multiforme].
Jeremić B; Grulicić D; Samardzić M; Antunović V; Joksimović M; Djurić Lj; Milicić B; Nikolić N
Srp Arh Celok Lek; 1997; 125(3-4):93-8. PubMed ID: 9221525
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
[TBL] [Abstract][Full Text] [Related]
5. Long-term survivors of glioblastoma: clinical features and molecular analysis.
Sonoda Y; Kumabe T; Watanabe M; Nakazato Y; Inoue T; Kanamori M; Tominaga T
Acta Neurochir (Wien); 2009 Nov; 151(11):1349-58. PubMed ID: 19730774
[TBL] [Abstract][Full Text] [Related]
6. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
McLendon RE; Halperin EC
Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892
[TBL] [Abstract][Full Text] [Related]
7. The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time.
Nafe R; Franz K; Schlote W; Schneider B
Oncol Rep; 2006 Sep; 16(3):555-62. PubMed ID: 16865255
[TBL] [Abstract][Full Text] [Related]
8. [The prognostic factors in astrocytic tumors: analysis by the Kaplan-Meier method and the Weibull log-linear model].
Hirano H; Asakura T; Yokoyama S; Kadota K; Kasamo S; Okahara K; Hirakawa W; Niiro M; Nakamura K; Nakayama M; Yamasaki I
No Shinkei Geka; 1996 Sep; 24(9):809-15. PubMed ID: 8827730
[TBL] [Abstract][Full Text] [Related]
9. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.
Schueller P; Micke O; Palkovic S; Schroeder J; Moustakis C; Bruns F; Schuck A; Wassmann H; Willich N
Strahlenther Onkol; 2005 Aug; 181(8):500-6. PubMed ID: 16044217
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
[TBL] [Abstract][Full Text] [Related]
11. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of p53 protein expression in glioblastoma.
Birner P; Piribauer M; Fischer I; Gatterbauer B; Marosi C; Ungersböck K; Rössler K; Budka H; Hainfellner JA
Oncol Rep; 2002; 9(4):703-7. PubMed ID: 12066196
[TBL] [Abstract][Full Text] [Related]
13. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.
Grunnet ML; O'Neill A; Gilbert M; Hellman R
Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748
[TBL] [Abstract][Full Text] [Related]
14. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients.
Guyotat J; Metellus P; Giorgi R; Barrie M; Jouvet A; Fevre-Montange M; Chinot O; Durand A; Figarella-Branger D
Acta Neurochir (Wien); 2009 Aug; 151(8):947-60. PubMed ID: 19499166
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
[TBL] [Abstract][Full Text] [Related]
16. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
17. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas.
Nafe R; Franz K; Schlote W; Schneider B
Clin Cancer Res; 2005 Mar; 11(6):2141-8. PubMed ID: 15788659
[TBL] [Abstract][Full Text] [Related]
18. [Intracranial ependymomas in adult patients. Retrospective analysis of 121 cases from the multicentric French study].
Metellus P; Barrie M; Figarella-Branger D; Chinot O; Giorgi R; Jouvet A; Guyotat J
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):66-75. PubMed ID: 17475290
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
20. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
Nobusawa S; Watanabe T; Kleihues P; Ohgaki H
Clin Cancer Res; 2009 Oct; 15(19):6002-7. PubMed ID: 19755387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
